Song et al. showed that galectin-3 modulates β-catenin levels and Wnt signaling by regulating the activity/phosphorylation of GSK3B via PI3K/AKT pathway in colon cancers [19]. The gene discussed is AKT1; the disease is malignant colon neoplasm.